Following are some drugs commonly used to treat the symptoms of bipolar
disorder during pregnancy:
cont. from
Lithium. Although effective in only a limited number of patients,
lithium
is a popular treatment for bipolar disorder. Recent studies have shown the teratogenicity rates are much lower than reported. The most common effects of
fetal exposure are high birth weight and "floppy-baby" syndrome.
Valproate and
carbamazepine. These anticonvulsants are associated with
major congenital malformations and carry a greater risk of birth defects than
lithium. Valproate and
carbamazepine have been linked to neural tube defects,
craniofacial anomalies, urogenital problems, growth retardation, microcephaly,
and heart defects.
Late last year, the American Epilepsy Society's pregnancy outcomes forum
panel recommended that valproate should not be prescribed as first line therapy
for any indication in women of childbearing age because it significantly
increases the risk of major malformations in infants who were exposed in utero.
Lamotrigine. This anticonvulsant is associated with a low overall rate of
fetal malformations, but it carries a higher rate of miscarriages and
stillbirths than seen in unmedicated women. The agent also has been linked to a
skin rash in infants who have different antigen characteristics than their
mothers.
Chlorpromazine. This first-generation antipsychotic often is used to treat
mania during pregnancy. It is among the best-studied of the antipsychotics in
pregnancy, and the data support its relative safety in this population. Related
compounds, such as trifluoperazine and
perphenazine, also may have low
teratogenic risk, although they are not as well studied as phenothiazine
chlorpromazine.
Lorazepam and
clonazepam. These benzodiazepines often are used to treat the
anxiety, agitation, and sleep disturbances that accompany bipolar disorder. They
have not been linked to significant increases in malformation rates, although
chronic use of benzodiazepines during pregnancy has been linked to withdrawal
symptoms in babies.
Olanzapine. One of the newer atypical antipsychotics,
olanzapine, is used
for acute mania and for prophylaxis against recurrent mania; however, data on
this and the other atypical antipsychotics in pregnancy are still too sparse to
make conclusions regarding their reproductive safety, according to Dr. Viguera.
Strategies for minimizing the risks associated with all of these drugs
include using monotherapy rather than a combination of drugs, and relying on the
lowest possible effective dose, Dr. Viguera said.
Folic acid supplementation--in
addition to a daily prenatal vitamin--may help reduce the increased risk of
neural-tube defects. She recommended that women taking anticonvulsants, in
particular, take 4 mg of supplemental folic acid per day during the
preconception period through the first trimester.
"All women taking these medications during the first trimester should obtain
a high-resolution ultrasound at 16-18 weeks to detect the presence of fetal
malformations," Dr. Viguera noted.
In addition, because drug metabolism changes during pregnancy, both maternal
and fetal serum drug levels should be monitored regularly.
next:
Effects of Atypical Antipsychotics
During Pregnancy
top .
pages 1 2 .
send to friend .
bipolar site
map
Reviewed: 03/2006
|